MabVax Therapeutics Announces Closing of Financing – PR Newswire (press release)

MabVax Therapeutics Announces Closing of Financing
PR Newswire (press release)
Each Unit consists of one share of common stock and a 30-month warrant to purchase one-half of one share of common stock (the “Warrant”). The Warrants are exercisable at $1.50 per each whole share of common stock. Laidlaw & Company (UK) Ltd. acted …

and more

…read more

Scroll to Top